The primary drug classes that were found to be the most associated with AD were (in descending order for support): cholinesterase inhibitors, NMDA receptor antagonists, serotonin reuptake inhibitors, HMG-coA reductase inhibitors, vitamin c, ascorbic acid, vitamin B12, and vitamin E. The gene discussed is HMGCR; the disease is Alzheimer disease.